Interferon alfa-n1

24 - place hematocrit tube rotor for Z287-A

Application A1V2PF2-NHEt is an in silico-derived inhibitor of apoptosis protein (IAP)-recruiting ligand for targeted protein degradatio and SNIPER (specific and non-genetic IAP-dependent protein erasers) development, launched in partnership with

An inactive control to be used in experiments with AGK2 has IC₅₀ values greater than 50 &microM on SIRT1 and SIRT2 and greater than 5 &microM on SIRT3.

AKT-IN-3 (compound E22) is a potent, orally active low hERG blocking Akt inhibitor, with 1.4 nM, 1.2 nM and 1.7 nM for Akt1 , Akt2 and Akt3 , respectively. AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family

AKT-IN-3 (compound E22) is a potent, orally active low hERG blocking Akt inhibitor, with 1.4 nM, 1.2 nM and 1.7 nM for Akt1 , Akt2 and Akt3 , respectively. AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family

N-terminal His6-tagged, recombinant human ALK, residues 1058-end Product Source: expressed by baculovirus in Sf21 cells Application Research Category Inflammation &amp Immunology Biochem/physiol Actions Protein Target: ALK Target Sub-Family: TK

N-terminal His6-tagged, recombinant human ALK, residues 1058-end Product Source: expressed by baculovirus in Sf21 cells Application Research Category Inflammation &amp Immunology Biochem/physiol Actions Protein Target: ALK Target Sub-Family: TK

Anifrolumab (anti-IFNAR1) is a type I interferon (IFN) receptor antagonist, a recombinant monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research.Purity&gt:95%

Anifrolumab (anti-IFNAR1) is a type I interferon (IFN) receptor antagonist, a recombinant monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research.Purity&gt:95%

Anifrolumab (anti-IFNAR1) is a type I interferon (IFN) receptor antagonist, a recombinant monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research.Purity&gt:95%

Anifrolumab (anti-IFNAR1) is a type I interferon (IFN) receptor antagonist, a recombinant monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research.Purity&gt:95%

General description Activin A receptor type 1 (ACVR1) gene encodes a transmembrane protein that belongs to the bone morphogenetic protein (BMP) type I receptors subfamily of the transforming growth factor-&#946: (TGF-&#946:) receptors. ACVR1 is a